- £1.02bn
- £1.41bn
- £1.93bn
- 79
- 88
- 13
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,710 | 1,458 | 1,643 | 2,047 | 1,930 |
Cost of Revenue | |||||
Gross Profit | 477 | 374 | 420 | 572 | 538 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,583 | 1,384 | 1,510 | 1,831 | 1,740 |
Operating Profit | 128 | 74.3 | 133 | 217 | 190 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 119 | 64.5 | 128 | 207 | 179 |
Provision for Income Taxes | |||||
Net Income After Taxes | 86.5 | 45.8 | 108 | 189 | 131 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 80.3 | 41.3 | 102 | 181 | 119 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 80.3 | 41.3 | 102 | 181 | 119 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.501 | 0.236 | 0.434 | 0.811 | 0.447 |
Dividends per Share |